PRESS RELEASES

RAYMEDICA® REPORTS HIGHER-THAN-ANTICIPATED TRAFFIC ON NUCLEUSARTHROPLASATY.COM WEBSITE

MINNEAPOLIS - April 27, 2007 - Raymedica, the Pioneer in Nucleus Arthroplasty has termed an “overwhelming success” to the debut of its nucleusarthroplasty.com website. The public evidently wants to know more about this ground breaking resource in the rapidly emerging field of non-fusion spinal surgery.

Nucleusarthroplasty.com is an Internet site designed to provide educational information for anyone engaged in the field of non-fusion spinal surgery. The website is free to physicians and the general public at www.nucleusarthroplasty.com.

“The world has become accustomed to finding any and all information on-line, especially information on emerging technologies for treatment of spinal disorders. Industry is also realizing the importance of having an educational Web site, and many will adopt accordingly,” stated John J. Viscogliosi, Chairman and Chief Executive Officer of Raymedica, LLC. Mr. Viscogliosi continued, “We as an organization felt that it was critical to develop a site such as nucleusarthroplasty.com where referring physicians, patients, industry and third-party payers could access information at one central location to significantly increase their knowledge level.”

Nucleusarthroplasty.com is primarily an educational website designed to provide valuable guidance to spine surgeons as they seek to provide more effective and less invasive options for the treatment of degenerative disc disease (DDD). The website was recently updated to include monographs on Biomechanics & Development, Surgical Techniques & Technologies. “We are still developing this aspect of our site and look forward to utilizing our website in forwarding our educational efforts,” added Mr. Viscogliosi.

About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus Arthroplasty having developed the world’s first nucleus replacement device in 1996. Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have been unresponsive to non-surgical treatment. Raymedica’s products are currently available in many countries worldwide, but are limited to investigational use only in the United States. For more information, visit the Company's website at http://www.raymedica.com.

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
 
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.


> Back to Press Releases

 

Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.